Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

SZSE:000766.SZ

13.05 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994
Revenue 1,322.5581,473.3451,470.7491,515.4821,111.8021,977.2062,094.5491,521.41850.083197.559208.415147.782127.648181.471169.587168.164159.856151.589141.337141.15399.872136.897160.995100.435504.187284.91270.987241.071163.868132.48999.435
Cost of Revenue 331.578410.35353.209352.84224.302339.902341.363324.066265.73196.44879.37672.23457.30276.35165.84865.56164.3467.12866.02758.77649.750.14139.43430.47470.477103.892114.27775.38947.6850.47349.94
Gross Profit 990.981,062.9951,117.541,162.642887.5011,637.3051,753.1871,197.344584.353101.111129.03975.54870.346105.12103.739102.60395.51684.4675.31182.37650.17286.756121.56269.961433.711181.017156.71165.682116.18882.01649.495
Gross Profit Ratio 0.7490.7210.760.7670.7980.8280.8370.7870.6870.5120.6190.5110.5510.5790.6120.610.5980.5570.5330.5840.5020.6340.7550.6970.860.6350.5780.6870.7090.6190.498
Reseach & Development Expenses 50.34345.8264.90963.51550.3366.91267.30351.5528.5820.2631.6680.710000000000000000000
General & Administrative Expenses 30.6729.36625.51330.099105.38873.39954.52239.7144.12814.85318.23913.79211.81641.7733.77733.80730.62130.88935.18235.46182.599148.29647.87154.762.41135.71821.75415.649.1816.3953.242
Selling & Marketing Expenses 653.269771.959815.145878.708856.7581,290.461,244.005702.623215.8563.73769.76648.57234.10257.16653.92853.21942.13336.09635.06634.75792.25371.96662.014213.00560.28238.70225.47534.20525.70622.93618.401
SG&A 683.939881.734840.658908.807962.1461,363.8591,298.527742.333259.97878.59188.00562.36445.91898.93687.70487.02672.75466.98570.24870.217274.852220.262109.883367.705122.69274.4247.22949.84434.88729.33221.643
Other Expenses 189.271-2.02882.94667.34449.42378.7571.4550.2315.1551.197-7.2921.953-1.7814.9224.2378.4761.8217.0882.813-0.198-9.687-17.07837.149-209.58552.29622.65818.8968.9572.077-0.382-0.003
Operating Expenses 923.5531,039.353988.5121,039.6671,061.8991,509.5281,442.805893.282363.785116.03123.64991.73375.391101.26889.88788.99374.74468.84271.89671.592275.338221.04112.346369.734130.77877.39149.47952.7436.29330.48121.936
Operating Income 67.427143.407139.167146.089-174.398158.678407.791299.691233.7594.80816.0193.2486.85811.4867.10620.57814.77612.3775.7118.789-275.025-178.484-20.621-366.587265.80193.917102.892103.92775.39152.42724.8
Operating Income Ratio 0.0510.0970.0950.096-0.1570.080.1950.1970.2750.0240.0770.0220.0540.0630.0420.1220.0920.0820.040.062-2.754-1.304-0.128-3.650.5270.330.380.4310.460.3960.249
Total Other Income Expenses Net -0.342-88.552-89.393-85.0810.745-2,171.4231.4550.2314.8420.925-7.2941.95315.58816.2973.95215.445-4.1753.9154.807-2.129-59.673-16.24137.285-209.34151.94621.5316.3158.8572.246-0.376-0.049
Income Before Tax 67.08554.85550.17459.624-355.832-2,012.745409.246299.921247.7815.7338.7255.2015.07716.40811.05829.05416.59719.5328.4658.623-284.775-194.72516.664-575.928317.747115.447119.207112.78477.63852.05124.751
Income Before Tax Ratio 0.0510.0370.0340.039-0.32-1.0180.1950.1970.2910.0290.0420.0350.040.090.0650.1730.1040.1290.060.061-2.851-1.4220.104-5.7340.630.4050.440.4680.4740.3930.249
Income Tax Expense 11.10711.62920.98525.6354.82830.19180.02642.83235.86-1.1313.5591.1091.2215.166-0.961-0.737-0.5830.70317.0310-50.566-15.15667.8457.01670.37833.65932.57317.1811.6425.1881.9
Net Income 56.43743.93430.15135.273-360.66-2,042.936330.858257.879213.4616.8635.1664.0923.85711.24112.01929.79117.1818.82916.518.476-245.679-194.2716.417-584.125241.91581.34683.3195.48465.99646.86322.851
Net Income Ratio 0.0430.030.0210.023-0.324-1.0330.1580.170.2510.0350.0250.0280.030.0620.0710.1770.1070.1240.1170.06-2.46-1.4190.102-5.8160.480.2860.3070.3960.4030.3540.23
EPS 0.060.050.0310.037-0.37-2.110.340.270.230.010.010.010.010.030.030.070.040.04-0.020.019-0.57-0.450.037-1.360.540.180.170.250.150.110.053
EPS Diluted 0.060.050.0310.037-0.37-2.110.340.270.230.010.010.010.010.030.030.070.040.04-0.020.019-0.57-0.450.037-1.360.540.180.170.250.150.110.053
EBITDA 219.001212.74210.587215.477-154.978-1,890.65518.155388.825319.41521.70126.77921.55811.89521.34929.41531.0739.05935.42423.75328.702-221.713-132.44391.469-475.945386.582116.019109.046112.94279.89551.53627.559
EBITDA Ratio 0.1660.1440.1430.142-0.139-0.9560.2470.2560.3760.110.1280.1460.0930.1180.1730.1850.2440.2340.1680.203-2.22-0.9670.568-4.7390.7670.4070.4020.4690.4880.3890.277